Literature DB >> 27002855

The Economic Burden of Autonomic Dysreflexia during Hospitalization for Individuals with Spinal Cord Injury.

Jordan W Squair1,2, Barry A B White1,3, Grace I Bravo4, Kathleen A Martin Ginis5, Andrei V Krassioukov1,6,7.   

Abstract

We sought to determine the economic burden of autonomic dysreflexia (AD) from the perspective of the Canadian healthcare system in a case series of individuals with spinal cord injury (SCI) presenting to emergency care. In doing so, we sought to illustrate the potential return on investments in the translation of evidence-informed practices and developments in the prevention, diagnosis, and management of AD. Activity-based costing methodology was employed to estimate the direct healthcare or hospitalization costs of AD following presentation to the emergency department. Differences in trends were noted between patients who were promptly diagnosed, managed, and discharged, and patients whose experience followed a less direct or ideal path to discharge. We recorded 29 emergency room visits for conditions ultimately diagnosed as AD. Overall, median length of stay was 3 days (interquartile range [IQR] = 1.25-5.75), but extended up to 103 consecutive days. Cost analysis revealed median healthcare costs of $5029 (IQR = $2397-9522) for hospital admissions for AD, with the highest estimated hospital cost for a single admission > $190,000. Emergency room admissions resulting from AD can result in dramatic healthcare costs. Delayed diagnosis and inefficient management of AD may lead to further complications, adding to the strain on already limited healthcare resources. Prompt recognition of AD; broader translation of evidence-informed practices; and novel diagnosis, self-management, and/or therapeutic/pharmaceutical applications may prove to mitigate the burden of AD and improve patient well-being.

Entities:  

Keywords:  clinical management of central nervous system injury; spinal cord injury; traumatic spinal cord injury

Mesh:

Year:  2016        PMID: 27002855     DOI: 10.1089/neu.2015.4370

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  4 in total

1.  Effect of intravesical botulinum toxin injection on symptoms of autonomic dysreflexia in a patient with chronic spinal cord injury: a case report.

Authors:  Il-Young Jung; Kyo Ik Mo; Ja-Ho Leigh
Journal:  J Spinal Cord Med       Date:  2017-05-09       Impact factor: 1.985

Review 2.  A Scoping Review of Self-Management Interventions Following Spinal Cord Injury.

Authors:  Amanda McIntyre; Stephanie L Marrocco; Samantha A McRae; Lindsay Sleeth; Sander Hitzig; Susan Jaglal; Gary Linassi; Sarah Munce; Dalton L Wolfe
Journal:  Top Spinal Cord Inj Rehabil       Date:  2020

Review 3.  Spinal cord stimulation for spinal cord injury patients with paralysis: To regain walking and dignity.

Authors:  Sheng-Tzung Tsai; Yu-Chen Chen; Hung-Yu Cheng; Chun-Hsiang Lin; Huan-Chen Lin; Chich-Haung Yang; Chung-Chao Liang; Shin-Yuan Chen
Journal:  Tzu Chi Med J       Date:  2020-08-26

4.  Quantitative assessment-based nursing intervention improves bowel function in patients with neurogenic bowel dysfunction after spinal cord injury: Study protocol for a randomized controlled study.

Authors:  Qionghua Yin; Can Wang; Jianhong Yu; Qiufang Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.